PLAAT4 and neoplasm: RARRES3 downregulation has been proven in multiple tumor types, including CRC tissues and re-expression of RARRES3 exerted tumor-suppressive effects (Jiang et al., 2005; Morales et al., 2014; Wang et al., 2015).